Αποτελέσματα Αναζήτησης
We will discuss the potential use of cannabinoids for treatment of cancer, focusing on primary outcome/care—tumor shrinkage and eradication, as well as secondary outcome/palliative care—improvement of life quality, including pain, appetite, sleep, and many more factors.
13 Μαρ 2024 · Cannabis and/or cannabinoid access and use by adults with cancer has outpaced the science supporting their clinical use. This guideline provides strategies for open, nonjudgmental communication between clinicians and adults with cancer about the use of cannabis and/or cannabinoids.
13 Μαρ 2024 · Adults with cancer using cannabis or cannabinoids should understand that the clinical evidence to support their use as cancer-directed therapy in humans is lacking.
13 Μαΐ 2022 · Right now, there simply isn’t enough evidence to prove that cannabinoids – whether natural or synthetic – can effectively treat cancer in patients, although research is ongoing. And there’s certainly no evidence that cannabis bought on the street can treat cancer.
For people with cancer, cannabis is being studied for its possible benefits in helping to manage certain side effects of cancer and its treatment. But cannabis can be harmful in certain situations, forms, and doses. Learning how cannabis works and how it can be safely used is important for everyone. In this section, you’ll find information ...
11 Μαρ 2022 · The following chapters provide an overview of the preclinical evidence on the effect of cannabinoids on cancer growth and metastasis, with the most relevant cannabinoid targets summarised in...
Cannabidiol use was most often reported as the anticancer cannabinoid with daily doses ranging from 10 to 800 mg. Tetrahydrocannabinol use was reported in six studies, with doses ranging from 4.8 to 7.5 mg. Two small trials published data on survival in patients with recurrent glioblastoma multiforme.
